![Behzad Aghazadeh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/05/2026
Dr. Behzad Aghazadeh is an Independent Director at Whitehawk Therapeutics, Inc., a Managing Partner & Portfolio Manager at Avoro Capital Advisor LLC and a Portfolio Manager & Managing Partner at Avoro Life Sciences Fund LLC.
He is on the Board of Directors at Whitehawk Therapeutics, Inc. and Aadi Subsidiary, Inc. He has over 25 years of experience.
Dr. Aghazadeh began his career as a research scientist, before joining Booz Allen Hamilton.
He has held investment roles at Bernstein Value Equities and Sio Capital Management.
Behzad served as the Executive Chairman of Immunomedics, a company developing targeted oncology therapies, from 2017 until the company’s $21B acquisition by Gilead in 2020.
He continues to serve on the boards of public and private biotechnology companies.
He received his master’s degree in Physics from the Ludwig-Maximilians-University and a PhD from Cornell University in Biochemistry & Biophysics.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 12/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 26/08/2021 |
Avoro Capital Advisor LLC
 Avoro Capital Advisor LLC Investment ManagersFinance AVCAP aims to achieve attractive returns with moderate risk. The firm invests primarily in the equity, debt and associated derivatives of companies operating in the life sciences sector and related industries with a focus on publicly traded, and late-stage private biotechnology companies. | Gestore di Portafoglio-Azioni | 01/07/2011 |
Avoro Life Sciences Fund LLC
 Avoro Life Sciences Fund LLC Investment Trusts/Mutual FundsMiscellaneous Acts as Hedge Fund | Corporate Officer/Principal | - |
Aadi Subsidiary, Inc.
 Aadi Subsidiary, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Direttore/Membro del Consiglio | 01/01/2021 |
Avoro Ventures LLC
 Avoro Ventures LLC Investment ManagersFinance Avoro Ventures invests in public and private companies located in the United States. The firm focuses on life sciences and biotechnology. It participates in seed, early, and late stage transactions. | Investitore di Private Equity | - |
| Società | Posizione | Fine |
|---|---|---|
| IMMUNOMEDICS, INC. | Presidente | 23/10/2020 |
Scribe Therapeutics, Inc.
 Scribe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops CRISPR-based genetic medicines | Direttore/Membro del Consiglio | - |
Strategy&
 Strategy& Miscellaneous Commercial ServicesCommercial Services Provides business strategy consulting services | Corporate Officer/Principal | - |
AllianceBernstein LP
 AllianceBernstein LP Financial ConglomeratesFinance AB is a research-driven investment adviser that is global in scope and client-centered in their approach. The firm’s global team of research professionals, whose disciplines include economics, fundamental equity, fixed income and quantitative research, gives them a competitive advantage in achieving investment success for their clients. Within these research disciplines, they also have investment professionals that focus on multi-asset, wealth management and alternative investment strategies. | Corporate Officer/Principal | - |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░ | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 13 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Avoro Life Sciences Fund LLC
Avoro Life Sciences Fund LLC Investment Trusts/Mutual FundsMiscellaneous Acts as Hedge Fund | Miscellaneous |
AllianceBernstein LP
AllianceBernstein LP Financial ConglomeratesFinance AB is a research-driven investment adviser that is global in scope and client-centered in their approach. The firm’s global team of research professionals, whose disciplines include economics, fundamental equity, fixed income and quantitative research, gives them a competitive advantage in achieving investment success for their clients. Within these research disciplines, they also have investment professionals that focus on multi-asset, wealth management and alternative investment strategies. | Finance |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sio Capital Management LLC
 Sio Capital Management LLC Investment ManagersFinance Sio Capital aims to invest capital in a global, healthcare-focused portfolio in order to generate attractive returns for their investors. The firm has a ‘value’ orientation with a strong attention to balance sheet quality and cash flow generation. Their long portfolios typically include growth at a reasonable price (GARP) and growth investments when attractive opportunities arise. For Sio Capital’s portfolios of short investments, they look for shorts that are ‘hyped up’ and whose valuations are predicated on expectations that the firm believes to be unattainable. | Finance |
Strategy&
Strategy& Miscellaneous Commercial ServicesCommercial Services Provides business strategy consulting services | Commercial Services |
venBio Partners LLC
 venBio Partners LLC Investment ManagersFinance venBio invests in companies located in the United States. The firm focuses on companies operating in the fields of life sciences sectors. It participates in early to late stage transactions. The firm acts as a lead investor. | Finance |
Avoro Capital Advisor LLC
Avoro Capital Advisor LLC Investment ManagersFinance AVCAP aims to achieve attractive returns with moderate risk. The firm invests primarily in the equity, debt and associated derivatives of companies operating in the life sciences sector and related industries with a focus on publicly traded, and late-stage private biotechnology companies. | Finance |
Aadi Subsidiary, Inc.
Aadi Subsidiary, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Scribe Therapeutics, Inc.
Scribe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops CRISPR-based genetic medicines | Health Technology |
Avoro Ventures LLC
Avoro Ventures LLC Investment ManagersFinance Avoro Ventures invests in public and private companies located in the United States. The firm focuses on life sciences and biotechnology. It participates in seed, early, and late stage transactions. | Finance |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
